INNOVATION1 BIOTECH INC. Debt Instrument, Convertible, Beneficial Conversion Feature
INNOVATION1 BIOTECH INC. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $170.44 thousand for the 6-month period ending 2024-02-29, per its 10-Q filed 2025-05-06.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2025-05-06
- INNOVATION1 BIOTECH INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2024-02-29 was $0.00, a 100.00% decline year-over-year.
- INNOVATION1 BIOTECH INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2023-11-30 was $170.44K, a 641.45% increase year-over-year.
- INNOVATION1 BIOTECH INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2023-08-31 was $0.00.
- INNOVATION1 BIOTECH INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2023-05-31 was -$51.78K.
- INNOVATION1 BIOTECH INC. debt instrument, convertible, beneficial conversion feature for fiscal 2023 was $56.53K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month | Debt Instrument, Convertible, Beneficial Conversion Feature 9 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|---|---|---|
| 2024-02-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-06 | $170.44K 10-Q · filed 2025-05-06 | $170.44K derived: sum of 3 quarters · filed 2025-05-06 | $118.67K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-11-30 | $170.44K 10-Q · filed 2025-01-27 | $170.44K derived: sum of 2 quarters · filed 2025-01-27 | $118.67K derived: sum of 3 quarters · filed 2025-01-27 | $203.99K derived: sum of 4 quarters · filed 2025-01-27 |
| 2023-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-17 | -$51.78K derived: sum of 2 quarters · filed 2024-01-17 | $33.54K derived: sum of 3 quarters · filed 2024-01-17 | $56.53K 10-K · filed 2024-01-17 |
| 2023-05-31 | -$51.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-09-13 | $33.54K derived: sum of 2 quarters · filed 2023-09-13 | $56.53K 10-Q · filed 2023-09-13 | |
| 2023-02-28 | $85.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-30 | $108.31K 10-Q · filed 2023-05-30 | ||
| 2022-11-30 | $22.99K 10-Q · filed 2023-01-17 |